Results of the present study showed that the proportion of high nuclear grade was 55% (33 out of 60 patients) and 22% (153 out of 705 patients) in TFE3-positive non-Xp11.2 translocation RCC group and TFE3-negative RCC group, respectively. This evidence concerns the gene TFE3 and renal cell carcinoma.